Health News

LONDON--(BUSINESS WIRE)--A new NHS-first, AI-enabled case-finding pathway has launched across North East Essex, aiming to improve the early detection of Oesophageal and stomach cancers, some of the hardest cancers to diagnose early and among those with the poorest outcomes in England. Delivered in partnership between AstraZeneca, C the Signs, NHS Suffolk and North East Essex Integrated Care Board, Health Innovation East and GP Primary Choice, the programme represents the first time in England t...

MARSEILLE, France--(BUSINESS WIRE)--Innate Pharma announces conference call and webcast for full year 2025 financial results...

ZURICH--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis (ALS), today announced the presentation of new clinical data from the global Phase 2 clinical trial (AP-101-02) evaluating the company’s lead program, AP-101, in patients with ALS. AP-101 is an investigational human-derived antibody directed against misfolded superoxide dismutase 1 (SOD1). AP-101 is...

TOKYO--(BUSINESS WIRE)--Kao Corporation (TOKYO:4452) today announced that its skincare brand Bioré will accelerate its international expansion as it enters the South Korean market and rolls out a globally unified campaign. As a core brand under Kao’s “Global Sharp Top” strategy—aimed at establishing leadership in key market segments through high-value products—Bioré plays a central role in driving the company’s global growth. Currently available in 66 countries and regions across Asia, the Amer...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK), today announced the U.S. Food and Drug Administration (FDA) approved an expanded label for BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) in dogs. The updated indication adds treatment and control of Asian longhorned tick (H. longicornis) and Gulf Coast tick (A. maculatum) for 12 months...

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN) today announced the launch of a proposed underwritten public offering (the “Offering”) of 5,000,000 shares of its Class A common stock, consisting of 3,980,000 shares being offered by certain selling stockholders and 1,020,000 newly issued shares being offered by Guardian as part of a non-dilutive “synthetic secondary” transaction, as described below. In addition, the selling stockholders intend to grant the un...

SAN MATEO, Calif.--(BUSINESS WIRE)--Franklin Templeton, a global investment leader and its specialist investment manager, Clarion Partners, today announced that Clarion Partners has acquired The Grand at Spokane, a newly delivered luxury senior living community and full-continuum senior care facility located in the Spokane, Washington area. The acquisition was made on behalf of one of Clarion’s commingled funds and underscores the firm’s continued focus on high-quality healthcare and specialize...

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced fourth quarter and full year 2025 financial results and provided a business update. “The launch of our second-generation Swoop® scanner, our Optive AI™ software, and the addition of a new market in the neurology office setting in...

IRVINE, Calif.--(BUSINESS WIRE)--Xponential Fitness, Inc. (NYSE: XPOF) (“Xponential” or the “Company”), one of the leading global franchisors of boutique health and wellness brands, has finalized a previously disclosed settlement with the Federal Trade Commission (“FTC”) to fully resolve the agency’s allegations relating to the Company’s past franchising disclosure practices. As part of the settlement, Xponential will pay the FTC $17.0 million for franchisee redress over a 12-month period. The...

WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL) (the “Company”), the trusted partner empowering physicians to transform health care in our communities, today announced that it will implement a reverse stock split (the “Reverse Stock Split”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), at a ratio of 1-for-25. The reverse stock split is expected to become effective on March 30, 2026, on or around 5:01 p.m. Eastern Time (“Effective Time”) and a...